HIF1α promotes Th9 cell differentiation: (i) metabolically through TCA cycle metabolite, Succinate, and (ii) transcriptionally by transactivating Il9 and Nos2 gene loci, further enhancing Th9 cell polarization and Th9 cell-mediated anti-tumor effector functions (Fig. 8). The gene discussed is IL9; the disease is neoplasm.